Modulation of IMPDH2, survivin, topoisomerase I and vimentin increases sensitivity to methotrexate in HT29 human colon cancer cells (Q34387990)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Modulation of IMPDH2, survivin, topoisomerase I and vimentin increases sensitivity to methotrexate in HT29 human colon cancer cells |
scientific article |
Statements
1 reference
Modulation of IMPDH2, survivin, topoisomerase I and vimentin increases sensitivity to methotrexate in HT29 human colon cancer cells (English)
1 reference
Silvia Peñuelas
1 reference
1 February 2005
1 reference
1 reference
272
1 reference
3
1 reference
696-710
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference